Literature DB >> 25934812

An evaluation of vancomycin dosing for complicated infections in pediatric patients.

Spencer H Durham1, Marroyln L Simmons2, Diana W Mulherin3, Jason A Foland4.   

Abstract

OBJECTIVE: To determine the incidence with which a vancomycin dosing regimen of 15 mg/kg per dose every 6 hours achieves steady-state trough concentrations of 15 to 20 mg/L in pediatric patients with complicated infections.
METHODS: We performed a retrospective chart review for patients admitted to our children's hospital between July 1, 2009, and June 30, 2011. Patients were included if they were between 1 month and 18 years of age, had at least 1 steady-state vancomycin trough obtained, received an initial vancomycin dose of 15 mg/kg per dose every 6 hours, and were being treated for a diagnosis of meningitis, pneumonia, osteomyelitis, bacteremia/sepsis, or endocarditis.
RESULTS: Seventy-four patients were enrolled, mean age of 4.2±3.9 years and weight of 17.0±11.2 kg. Five (6.8%) patients obtained an initial trough of 15 to 20 mg/L. Patients between 1.0 and 5.9 years of age were significantly less likely to achieve an initial trough of 15 to 20 mg/L compared with other age groups evaluated (P=.041). Thirty-four patients with initial subtherapeutic troughs received a dose adjustment and a follow-up vancomycin trough. Of these patients, 15 (44.1%) achieved a trough between 15 and 20 mg/L. The median dose for patients achieving a therapeutic trough at any point during the study was 80 mg/kg per day.
CONCLUSIONS: A vancomycin dosing regimen of 15 mg/kg per dose every 6 hours is not likely to achieve a trough concentration of 15 to 20 mg/L in pediatric patients with complicated infections. An initial regimen of 80 mg/kg per day for these patients may be more likely to result in therapeutic steady-state concentrations of vancomycin.
Copyright © 2015 by the American Academy of Pediatrics.

Entities:  

Keywords:  child; infection; pediatrics; pharmacokinetics; vancomycin; vancomycin serum concentrations

Mesh:

Substances:

Year:  2015        PMID: 25934812     DOI: 10.1542/hpeds.2014-0081

Source DB:  PubMed          Journal:  Hosp Pediatr        ISSN: 2154-1671


  9 in total

Review 1.  Determining the optimal vancomycin daily dose for pediatrics: a meta-analysis.

Authors:  Geisa Cristina da Silva Alves; Samuel Dutra da Silva; Virginia Paula Frade; Danielle Rodrigues; André de Oliveira Baldoni; Whocely Victor de Castro; Cristina Sanches
Journal:  Eur J Clin Pharmacol       Date:  2017-08-04       Impact factor: 2.953

Review 2.  Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections in Children: a Reappraisal of Vancomycin.

Authors:  Roopali Sharma; Margaret R Hammerschlag
Journal:  Curr Infect Dis Rep       Date:  2019-09-05       Impact factor: 3.725

3.  Vancomycin Use in a Paediatric Intensive Care Unit of a Tertiary Care Hospital.

Authors:  Kannan Sridharan; Amal Al-Daylami; Reema Ajjawi; Husain Am Al Ajooz
Journal:  Paediatr Drugs       Date:  2019-08       Impact factor: 3.022

4.  Evaluation of vancomycin initial trough levels in children: A 1-year retrospective study.

Authors:  Muhammad Salem; Ahmed Khalil; Asmaa Mohamed; Ahmed Elmasoudi
Journal:  SAGE Open Med       Date:  2020-08-25

Review 5.  Vancomycin Dosing in Children With Overweight or Obesity: A Systematic Review and Meta-analysis.

Authors:  Manaswitha Khare; Aniqa Azim; Garrett Kneese; Meredith Haag; Kelsey Weinstein; Kyung E Rhee; Byron Alexander Foster
Journal:  Hosp Pediatr       Date:  2020-03-25

6.  Vancomycin Dosage and Its Association with Clinical Outcomes in Pediatric Patients with Gram-Positive Bacterial Infections.

Authors:  Sooyoung Shin; Hyun Joo Jung; Sang-Min Jeon; Young-Joon Park; Jung-Woo Chae; Hwi-Yeol Yun
Journal:  Risk Manag Healthc Policy       Date:  2020-06-29

7.  Steady-state Pharmacokinetics of Vancomycin in Children Admitted to Pediatric Intensive Care Unit of a Tertiary Referral Center.

Authors:  Nitin B Mali; Milind S Tullu; Poorwa P Wandalkar; Siddharth P Deshpande; Vinod C Ingale; Chandrahas T Deshmukh; Nithya J Gogtay; Urmila M Thatte
Journal:  Indian J Crit Care Med       Date:  2019-11

8.  Population pharmacokinetics and dose optimization of vancomycin in neonates.

Authors:  Soon Min Lee; Seungwon Yang; Soyoung Kang; Min Jung Chang
Journal:  Sci Rep       Date:  2021-03-17       Impact factor: 4.379

9.  Practical approaches to improve vancomycin-related patient outcomes in pediatrics- an alternative strategy when AUC/MIC is not feasible.

Authors:  Kashif Hussain; Muhammad Sohail Salat; Shahzad Rauf; Manoj Rathi; Midhat Khan; Fizzah Naz; Wasif Ahmed Khan; Rahila Ikram; Gul Ambreen
Journal:  BMC Pharmacol Toxicol       Date:  2022-08-20       Impact factor: 2.605

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.